FindTrial
Sign In

Persistence and compliance with secondary prevention medication in the ischemic stroke and transient ischemic attack patients

Persistence and compliance with secondary prevention medication in the ischemic stroke and transient ischemic attack patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004297
Enrollment
Unknown
Registered
2014-02-25
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Two groups:with medication education by pharmacisit vs without

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged between 14 and 80 years; 2) The patients were diagnosed and classified ischemic stroke and TIA according to guidelines of American stroke Association(ASA); 3) The first onset of ischemic stroke and TIA(within two weeks); 4) The patients have at least one cardiovascular risk factors can be adjusted, such as hypertension, high cholesterol and high blood sugar; 5) Signed informed consent.

Exclusion criteria

Exclusion criteria: 1) The patients who have cognitive dysfunction, mental disorders, coma (Glasgow coma score <4), or aphasia, and cannot be complete experiment; 2) The patients who have severe heart and lung disease, liver and kidney dysfunction, cancer and so on; 3) The patient who cannot coordinate and follow-up; 4) pregnant women; 5) Participated the other clinical experimenters nearly three months.

Design outcomes

Primary

MeasureTime frame
persistence;adherence;—

Countries

China

Contacts

Public ContactZhong Mingkang

Department of Pharmacy, Huashan Hospital, Fudan University

mkzhong@medmail.com.cn+86 13917650866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026